Tenet Healthcare director J. Robert Kerrey sells $3.17m in stock

J. Robert Kerrey, a director at Tenet Healthcare, recently sold a total of $3,167,330 worth of common stock on September 14, 2026. This sale comprised three separate transactions, with 5,483 shares sold at prices ranging from $262.43 to $263.37, 4,025 shares sold at prices between $263.45 and $264.44, and 2,502 shares sold at prices between $264.45 and $265.02.

The overall sale spanned a price range of $262.43 to $265.02 per share. As a result of these transactions, Kerrey now holds 4,794 shares of Tenet Healthcare common stock. The company's stock has been trading close to its 52-week high of $283.05, having generated a 33.75% return year-to-date. Despite this strong performance, InvestingPro analysis indicates that Tenet Healthcare remains undervalued compared to its Fair Value, potentially offering upside for investors.

The healthcare company currently boasts a P/E ratio of 10.35 and a market capitalization of $21.4 billion. Analyst firms have been upbeat about Tenet Healthcare's prospects, with firms like Raymond James, UBS, and Cantor Fitzgerald raising their price targets. These updates, along with Kerrey's recent sale, suggest that Tenet Healthcare is undergoing financial adjustments and strategic evaluations.